• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

For VCs, the game right now is musical chairs

September 3, 2021 by David Barret Leave a Comment

In many ways, there has never been a better time to be a venture capitalist. Nearly everyone in the industry is raking in money, either through long-awaited exits or because more capital flooding into the industry has meant more money in management fees  — and sometimes both.

Still, a growing number of early-stage investors with whom we talk to on a routine basis are wary about the pace of dealmaking. It’s not just that it’s a lot harder to write checks at what feels like a reasonable clip at the moment, or that most VCs feel they can no longer afford to be price sensitive. Many of the founders with whom they work are being handed follow-on checks before figuring out how best to deploy their last round of funding.

Consider that from 2016 through 2019, an average of 35 deals a month featured rounds of $100 million or more, according to the data company CB Insights. This year, we’re seeing nearly four times that number each month. The froth is hardly contained to maturing companies. According to CB Insights’s data, the median U.S. Series A valuation hit $42 million in the second quarter, driven in part crossover investors like Tiger Global, which closed 1.26 deals per business day in Q2. (Andreessen Horowitz wasn’t far behind.)

It makes for some bewildering times, including for longtime investor Jeff Clavier, the founder the early-stage venture firm Uncork Capital. Like many of his peers, Clavier is benefiting from the booming market. Among Uncork’s portfolio companies, for example is LaunchDarkly, a company that helps software developers avoid missteps. The seven-year-old company announced $200 million in Series D funding last month at a $3 billion valuation. That’s triple the valuation it was assigned early last year.

“It’s an awesome company, so I’m very excited for them,” says Clavier.

At the same time, he adds, “You have to put this money to work in a very smart way.”

That’s not so easy in this market, where founders are inundated with interest and, in some cases, are talking term sheets after the first Zoom with an investor. (“The most absurd thing we’ve heard are funds that are making decisions after a 30-minute call with the founder,” says TX Zhou, the cofounder of L.A.-based seed-stage firm Fika Ventures, which itself just tripled the amount of assets it’s managing.)

More money can mean a much longer lifeline for a company. But as many investors have learned the hard way, it can also serve as a distraction, as well as hide fundamental issues with a business until it’s too late to address them.

Taking on more money also oftentimes goes hand-in-hand with a bigger valuation, and lofty valuations comes with their own positives and negatives. On the plus side, of course, big numbers can attract more attention to a company from the press, from customers, and from potential new hires.  At the same time, “The more money you raise, the higher the valuation it is, it catches up with you on the next round, because you got to clear that watermark,” says Renata Quintini of the venture firm Renegade Partners, which focuses largely on Series B-stage companies.

Again, in today’s market, trying to slow down isn’t always possible. Quintini says that some founders her firm has talked to have said, “‘I’m not going to raise any more because I cannot go faster; I cannot deploy more than my model is already supporting.’” For others, she continues, “You’ve got to look at what’s happening around you, and sometimes if your competitors are raising and they’re going to have a bigger war chest . . and [they’re] pushing the market forward . . . and maybe they can out-hire you or they can outspend you in certain areas where they can generate more traction than you . . .” that next check, often at the higher valuation, begins to look like the only option.

Many VCs have argued that today’s valuations make sense because companies are creating new markets, growing faster than before, and have more opportunities to expand globally, and certainly, in some cases, that it is true. Indeed, companies that were previously believed to be richly priced by their private investors, like Airbnb and Doordash, have seen their valuations soar as publicly traded companies.

Yet it’s also true that for many more companies, “valuation is completely disconnected from the [companies’] multiples,” says Clavier, echoing what other VCs acknowledge privately.

That might seem to be the kind of problem that investors love to face. But as been the case for years now, that depends on how long this go-go market lasts.

Clavier says that one of his own companies that “did a great Series A and did a great Series B ahead of its time is now being preempted for a Series C, and the valuation is just completely disconnected from their actual reality.”

He said he’s happy for the outfit “because I have no doubt they will catch up. But this is the point: they will have to catch up.”

For more from our conversation with Clavier, by the way, you can listen here.

Source Link For VCs, the game right now is musical chairs

David Barret
David Barret

Related posts:

  1. The best cheap PS Vita prices, sales and deals in September 2021
  2. U.S. House Speaker Pelosi pledges action on bill in response to Texas abortion law
  3. Jordan’s water crisis deepens as climate changes, population grows
  4. Hyundai’s luxury brand Genesis to be all-electric by 2030

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Newly Spotted Vaquita Babies Offer Glimmer Of Hope For World’s Rarest Marine Mammal
  • Do Bees Really “Explode” When They Mate? Yes, Yes They Do
  • How Do We Brush A Hippo’s Teeth?
  • Searching For Nessie: IFLScience Takes On Cryptozoology
  • Your Halloween Pumpkin Could Be Concealing Toxic Chemicals – And Now We Know Why
  • The Aztec Origins Of The Day Of The Dead (And The Celtic Roots Of Halloween)
  • Large, Bright, And Gold: Get Ready For The Biggest Supermoon Of The Year
  • For Just Two Days A Year, These Male Toads Turn A Jazzy Bright Yellow. Now We Know Why
  • Interstellar Comet 3I/ATLAS Is Back From Behind The Sun – Still Not An Alien Spacecraft, Though
  • Bowhead Whales Can Live For 200 Years – This May Explain Their Extraordinary Longevity
  • Trump Orders First Nuclear Weapons Test In The US Since 1992 – Here’s What You Need To Know
  • Tiny Triceratops-Tackling Tyrannosaur Was Its Own Species, Not A Baby T. Rex
  • What Makes Ammolite Gemstones, A Rare Kind Of Fossilized Ammonite, So Vibrant? It’s All In The Nacre
  • Something Melted This Tesla’s Windscreen. Could It Have Been A World-First Meteorite Collision?
  • Carnivorous “Death-Ball” Sponge Among 30 New Deep-Sea Weirdos Discovered In The Southern Ocean
  • Chimps Can Revise Beliefs When Confronted With Conflicting Evidence. Can You?
  • Explosive Airbursts, Like Tunguska, Might Be Hiding Among “Halloween Fireballs” Meteor Shower
  • One Of The World’s Rarest Penguins Is Actually Three Subspecies In A Trench Coat
  • “I Am The Allergen”: The Super-Rare Condition That Makes Everyone Else Allergic To You
  • 42,000-Year-Old Yellow Crayon Suggests Neanderthals Created Art – And It’s Still Sharp Too
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version